Abstract

Nanophthalmos is a rare condition defined by a small, structurally normal eye with resultant high hyperopia. While six genes have been implicated in this hereditary condition (MFRP, PRSS56, MYRF, TMEM98, CRB1,VMD2/BEST1), the relative contribution of these to nanophthalmos or to less severe high hyperopia (≥ + 5.50 spherical equivalent) has not been fully elucidated. We collected probands and families (n = 56) with high hyperopia or nanophthalmos (≤ 21.0 mm axial length). Of 53 families that passed quality control, plausible genetic diagnoses were identified in 10/53 (18.8%) by high-throughput panel or pooled exome sequencing. These include 1 TMEM98 family (1.9%), 5 MFRP families (9.4%), and 4 PRSS56 families (7.5%), with 4 additional families having single allelic hits in MFRP or PRSS56 (7.5%). A novel deleterious TMEM98 variant (NM_015544.3, c.602G>C, p.(Arg201Pro)) segregated with disease in 4 affected members of a family. Multiple novel missense and frameshift variants in MFRP and PRSS56 were identified. PRSS56 families were more likely to have choroidal folds than other solved families, while MFRP families were more likely to have retinal degeneration. Together, this study defines the prevalence of nanophthalmos gene variants in high hyperopia and nanophthalmos and indicates that a large fraction of cases remain outside of single gene coding sequences.

Details

Title
Novel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort
Author
Prasov, Lev 1 ; Guan, Bin 2 ; Ullah, Ehsan 2 ; Archer, Steven M. 3 ; Ayres, Bernadete M. 3 ; Besirli, Cagri G. 3 ; Wiinikka-Buesser, Laurel 3 ; Comer, Grant M. 3 ; Del Monte, Monte A. 3 ; Elner, Susan G. 3 ; Garnai, Sarah J. 3 ; Huryn, Laryssa A. 2 ; Johnson, Kayla 3 ; Kamat, Shivani S. 3 ; Lieu, Philip 3 ; Mian, Shahzad I. 3 ; Rygiel, Christine A. 3 ; Serpen, Jasmine Y. 4 ; Pawar, Hemant S. 3 ; Brooks, Brian P. 2 ; Moroi, Sayoko E. 5 ; Richards, Julia E. 3 ; Hufnagel, Robert B. 2 

 University of Michigan, Department of Ophthalmology and Visual Sciences, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan, Department of Human Genetics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 National Eye Institute, National Institutes of Health, Ophthalmic Genetics and Visual Function Branch, Bethesda, USA (GRID:grid.280030.9) (ISNI:0000 0001 2150 6316) 
 University of Michigan, Department of Ophthalmology and Visual Sciences, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan, Department of Ophthalmology and Visual Sciences, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); National Eye Institute, National Institutes of Health, Ophthalmic Genetics and Visual Function Branch, Bethesda, USA (GRID:grid.280030.9) (ISNI:0000 0001 2150 6316); Case Western Reserve University School of Medicine, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847) 
 University of Michigan, Department of Ophthalmology and Visual Sciences, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); The Ohio State University, Department of Ophthalmology and Visual Sciences, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471574257
Copyright
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.